The VCCC Alliance represents a thriving network of cancer research and clinical trials, including early phase clinical trials. However, translating a discovery into an early phase clinical trial can be a lengthy process. It can also be difficult to connect eligible patients to relevant early phase trials due to a lack of awareness of these trials among both clinicians and patients.
More focus is needed to reduce the barriers that researchers and clinicians face when they interact with the pharmaceutical industry in order to gain access to novel drugs to use in a clinical trial or seek investment to develop a novel idea.
We’re focused on increasing access to novel therapies for patients where standard treatment options have been unsuccessful, to improve their quality of life and hopes for survival.
"As a cancer survivor, I know first-hand the value of having viable treatment options available to you. This program stands to increase the opportunities for patients to participate in early phase clinical trials, giving hope to people who are not suited to conventional treatments.”
- Natalie Diepenhorst, Consumer Representative